Challenges and recommendations for early identification of metastatic disease in prostate cancer

E. David Crawford; Nelson N. Stone; Evan Y. Yu; Phillip J. Koo; Stephen J. Freedland; Susan F. Slovin; Leonard G. Gomella; E. Roy Berger; Thomas E. Keane; Paul Sieber; Neal D. Shore; Daniel P. Petrylak

doi:10.1016/j.urology.2013.10.026

Challenges and recommendations for early identification of metastatic disease in prostate cancer

E. David Crawford, Nelson N. Stone, Evan Y. Yu, Phillip J. Koo, Stephen J. Freedland, Susan F. Slovin, Leonard G. Gomella, E. Roy Berger, Thomas E. Keane, Paul Sieber, Neal D. Shore, Daniel P. Petrylak

Research output: Contribution to journal › Review article › peer-review

83 Scopus citations

Abstract

Prostate cancer is often associated with metastases to bone and/or soft tissue. The progression to metastatic castrate-resistant prostate cancer is a seminal event in disease progression affecting treatment decisions. A multidisciplinary group was convened to review the currently available imaging guidelines for metastatic disease in prostate cancer and found no consensus on eligibility criteria, type of imaging modality, and the frequency of scanning for detecting metastatic disease. The aim of this review was to present the recommendations from the group to identify optimal strategies for early identification of metastases in patients with prostate cancer.

Original language	English
Pages (from-to)	664-669
Number of pages	6
Journal	Urology
Volume	83
Issue number	3
DOIs	https://doi.org/10.1016/j.urology.2013.10.026
State	Published - 2014

Access to Document

10.1016/j.urology.2013.10.026

Cite this

@article{4edbb65a64964c0c9374c69b89e8488d,

title = "Challenges and recommendations for early identification of metastatic disease in prostate cancer",

abstract = "Prostate cancer is often associated with metastases to bone and/or soft tissue. The progression to metastatic castrate-resistant prostate cancer is a seminal event in disease progression affecting treatment decisions. A multidisciplinary group was convened to review the currently available imaging guidelines for metastatic disease in prostate cancer and found no consensus on eligibility criteria, type of imaging modality, and the frequency of scanning for detecting metastatic disease. The aim of this review was to present the recommendations from the group to identify optimal strategies for early identification of metastases in patients with prostate cancer.",

author = "Crawford, {E. David} and Stone, {Nelson N.} and Yu, {Evan Y.} and Koo, {Phillip J.} and Freedland, {Stephen J.} and Slovin, {Susan F.} and Gomella, {Leonard G.} and Berger, {E. Roy} and Keane, {Thomas E.} and Paul Sieber and Shore, {Neal D.} and Petrylak, {Daniel P.}",

year = "2014",

doi = "10.1016/j.urology.2013.10.026",

language = "English",

volume = "83",

pages = "664--669",

journal = "Urology",

issn = "0090-4295",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Challenges and recommendations for early identification of metastatic disease in prostate cancer

AU - Crawford, E. David

AU - Stone, Nelson N.

AU - Yu, Evan Y.

AU - Koo, Phillip J.

AU - Freedland, Stephen J.

AU - Slovin, Susan F.

AU - Gomella, Leonard G.

AU - Berger, E. Roy

AU - Keane, Thomas E.

AU - Sieber, Paul

AU - Shore, Neal D.

AU - Petrylak, Daniel P.

PY - 2014

Y1 - 2014

N2 - Prostate cancer is often associated with metastases to bone and/or soft tissue. The progression to metastatic castrate-resistant prostate cancer is a seminal event in disease progression affecting treatment decisions. A multidisciplinary group was convened to review the currently available imaging guidelines for metastatic disease in prostate cancer and found no consensus on eligibility criteria, type of imaging modality, and the frequency of scanning for detecting metastatic disease. The aim of this review was to present the recommendations from the group to identify optimal strategies for early identification of metastases in patients with prostate cancer.

AB - Prostate cancer is often associated with metastases to bone and/or soft tissue. The progression to metastatic castrate-resistant prostate cancer is a seminal event in disease progression affecting treatment decisions. A multidisciplinary group was convened to review the currently available imaging guidelines for metastatic disease in prostate cancer and found no consensus on eligibility criteria, type of imaging modality, and the frequency of scanning for detecting metastatic disease. The aim of this review was to present the recommendations from the group to identify optimal strategies for early identification of metastases in patients with prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=84896728895&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2013.10.026

DO - 10.1016/j.urology.2013.10.026

M3 - Review article

C2 - 24411213

AN - SCOPUS:84896728895

SN - 0090-4295

VL - 83

SP - 664

EP - 669

JO - Urology

JF - Urology

IS - 3

ER -

Challenges and recommendations for early identification of metastatic disease in prostate cancer

Abstract

Access to Document

Fingerprint

Cite this